Download the Whitepaper
OxPL-apoB and OxPL-apo(a): Oxidized Phospholipid Biomarkers for Therapeutic Monitoring
OxPL-apoB and OxPL-apo(a): Oxidized Phospholipid Biomarkers for Therapeutic Monitoring
Successfully Executing Biomarker Strategies
Medpace’s central laboratories offers a unique advantage for Sponsors seeking advanced biomarker analysis through its exclusive research rights from Kleanthi Diagnostics for OxPL-apoB and OxPL-apo(a). These assays are derived from and validated against the original gold-standard methods developed in Dr. Sotirios Tsimikas’ laboratory, ensuring scientific rigor and reliability. As the only reference lab to offer both OxPL-apoB and OxPL-apo(a) testing, Medpace also provides optional panels including Lp(a), Lp(a)-cholesterol, apoB, and inflammatory markers for comprehensive lipid and inflammatory profiling. Developed in collaboration with leading experts in Lp(a), oxidized lipids, and lipoprotein biology, these assays are fully suited for both GCP-aligned clinical trials and observational research.
Click image to access full whitepaper.
Global Labs – Fully Integrated for Efficiency
Since most clinical trial requires laboratory support, having wholly-owned entities with a broad range of capabilities and comprehensive test menus provides built-in efficiencies and collaboration. In concert with the Medpace CRO or working on standalone projects, experts from our central laboratories and bioanalytical laboratory can help plan and execute your testing needs.